Chemplast Sanmar (CHEMPLASTS) Q2 26/27 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 26/27 earnings summary
5 Nov, 2026Executive summary
Q2 FY27 consolidated revenue was ₹1,323.21 crore, up 28% YoY; EBITDA was ₹111 crore and net loss narrowed to ₹5.45 crore from ₹51.04 crore.
H1 FY27 revenue was ₹2,447.87 crore, up 15% YoY; EBITDA loss was ₹115 crore and net loss widened to ₹181.03 crore.
Statutory auditors issued unmodified limited-review reports on the unaudited standalone and consolidated results.
Financial highlights
Q2 consolidated loss before exceptional items and tax was ₹8.51 crore versus ₹62.19 crore; H1 loss was ₹240.77 crore versus ₹148.60 crore.
Standalone Q2 revenue rose 11% YoY to ₹622.14 crore; EBITDA was ₹52 crore versus ₹18 crore, and net loss was ₹11.48 crore versus ₹35.53 crore.
H1 standalone revenue was ₹1,214.46 crore versus ₹1,053.40 crore; net loss narrowed to ₹60.77 crore from ₹63.95 crore.
Consolidated Q2 EBITDA margin was 8%; standalone EBITDA margin was 8% versus 3% in Q2 FY26.
Outlook and guidance
Paste PVC demand is expected to remain healthy through the festive period; new grades developed using existing infrastructure aim to expand volumes.
CMCD order commitments are nearly full for FY27 sales; management expects a strong Q4 and remains focused on its ₹1,000 crore revenue target for next year.
R-32 capacity of 20 kt is expected to be fully operational by Q4 FY27, with commercial operations expected by FY27-end.
Civil and infrastructure work for the next CMCD multipurpose block is targeted for completion by Q3 FY27; no specific bottom-line guidance was given.
Latest events from Chemplast Sanmar
- Record pre-exceptional PBT rose 7% as Cuddalore margins and lower costs lifted results.CHEMPLASTS
Q4 17/18 - Chloromethanes margins lifted FY19 PBT as a major scheme reshaped the business.CHEMPLASTS
Q4 18/19 - EBITDA margin rose to 30.7%; consolidated profit included major investment-redemption gains.CHEMPLASTS
Q4 20/21 - Higher depreciation, finance costs and COVID-19 pressure drove a sharp FY20 profit decline.CHEMPLASTS
Q4 19/20 - Record FY22 performance and IPO-led deleveraging fund the next capacity-growth phase.CHEMPLASTS
Q4 21/22 - Price and energy pressure cut FY23 earnings as major growth projects advanced.CHEMPLASTS
Q4 22/23 - Revenue rose 2% YoY but EBITDA turned negative amid high costs and market pressures.CHEMPLASTS
Q1 26/27 - Q1 FY25 saw strong revenue and profit growth, led by specialty chemicals and CMC expansion.CHEMPLASTS
Q1 24/25 - FY25 revenue and EBITDA surged, led by specialty chemicals; net loss narrowed despite PVC headwinds.CHEMPLASTS
Q4 24/25